We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Missing Audit Trails Raise Suspicion During FDA Inspections
Missing Audit Trails Raise Suspicion During FDA Inspections
February 2, 2006
FDA may have changed its sense of urgency on Part 11 and electronic record security controls as the agency’s own emphasis appeared to wane, but one constant remains: Audit trails are critically important when dealing with FDA inspectors, experts tell GMP.